BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1952708)

  • 1. [A new case of relapsing hemolytic and uremic syndrome].
    Barsaoui S; Haffani M; Oueslati A; Toumi NH; Bousnina S
    Ann Pediatr (Paris); 1991 Sep; 38(7):487-90. PubMed ID: 1952708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
    Zimmerhackl LB; Besbas N; Jungraithmayr T; van de Kar N; Karch H; Karpman D; Landau D; Loirat C; Proesmans W; Prüfer F; Rizzoni G; Taylor MC;
    Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
    Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic uremic syndrome. Evaluation of clinical and prognostic factors].
    Palomeque Rico A; Pastor Durán X; Molinero Egea C; Roca González A
    An Esp Pediatr; 1993 Nov; 39(5):391-4. PubMed ID: 8285450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.
    Bresin E; Daina E; Noris M; Castelletti F; Stefanov R; Hill P; Goodship TH; Remuzzi G;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical presentation and prognostic factors in primary hemolytic-uremic syndrome in adults].
    Pérez Fontán M; Martul EV; Fernández Rivera C; Alvarez A; Fernández Daza J; Valdés F
    Rev Clin Esp; 1989 Nov; 185(7):341-4. PubMed ID: 2623247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of hemolytic uremic syndrome in children. Importance of extrarenal involvement].
    Guyot C; Daniel MD; Roze JC; Renoult E; Dubigeon P; Buzelin F
    Arch Fr Pediatr; 1986 Apr; 43(4):253-8. PubMed ID: 3767586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
    Candinas D; Keusch G; Schlumpf R; Burger HR; Gmür J; Largiadèr F
    Schweiz Med Wochenschr; 1994 Oct; 124(41):1789-99. PubMed ID: 7973505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome: a review.
    McLigeyo SO
    East Afr Med J; 1999 Mar; 76(3):148-53. PubMed ID: 10442115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot manifestations of the thrombotic thrombocytopenic purpura hemolytic-uremic syndrome: a review and case report.
    Bibbo C; Davis WH
    J Foot Ankle Surg; 2005; 44(4):301-6. PubMed ID: 16012439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.
    Edey MM; Mead PA; Saunders RE; Strain L; Perkins SJ; Goodship TH; Kanagasundaram NS
    Am J Kidney Dis; 2008 Mar; 51(3):487-90. PubMed ID: 18295065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic uremic syndrome: defining the need for long-term follow-up.
    Small G; Watson AR; Evans JH; Gallagher J
    Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hemolytic uremic syndrome during oral contraception.
    Hauglustaine D; Van Damme B; Vanrenterghem Y; Michielsen P
    Clin Nephrol; 1981 Mar; 15(3):148-53. PubMed ID: 6168423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.